| Mariana Tristao Green, CNM | |
|
694 Good Dr, Lancaster, PA 17601-2433 | |
| (717) 397-8177 | |
| Not Available |
| Full Name | Mariana Tristao Green |
|---|---|
| Gender | Female |
| Speciality | Advanced Practice Midwife |
| Location | 694 Good Dr, Lancaster, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730952128 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | MW010760 (Pennsylvania) | Secondary |
| 367A00000X | Advanced Practice Midwife | (* (Not Available)) | Primary |
| Entity Name | Susquehanna Valley Womens Health Care Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952398125 PECOS PAC ID: 8527056670 Enrollment ID: O20040505001438 |
News Archive
Midwest Research Institute (MRI), one of the nation's leading independent research organizations, with more than 65-years of experience in scientific research, has been awarded a $31 million contract from the National Institute of Environmental Health Sciences. Under the 5-year contract, MRI scientists will provide chemical procurement, handling, and analytical chemistry services requested by the National Toxicology Program (NTP) for toxicology studies in progress throughout the U.S.
A new study by the University of Toronto, found the lifetime prevalence of suicide attempts among adults who had been exposed to chronic parental domestic violence during childhood was 17.3% compared to 2.3% among those without this childhood adversity.
USC Stem Cell researcher Min Yu, MD, PhD, is one of five early-career scientists to be named a 2015 Pew-Stewart scholar for cancer research. As part of this honor, she will receive $240,000 over four years to advance the understanding of metastatic breast cancer.
St. Jude Medical Center has earned Magnet recognition, a coveted national honor earned by only 8 percent of U.S. hospitals. This award is the highest accolade in nursing excellence that any hospital can receive.
Atox Bio, a clinical stage biotechnology company engaged in the development of novel immunemodulators for severe infections in critically ill patients, announced today that the U.S. Food and Drug Administration has granted Fast Track designation to AB103, its lead product, currently in development for the treatment of Necrotizing Soft Tissue Infections (NSTI).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mariana Tristao Green, CNM 5024 Constitution Ave, Harrisburg, PA 17109-5552 Ph: (239) 825-0345 | Mariana Tristao Green, CNM 694 Good Dr, Lancaster, PA 17601-2433 Ph: (717) 397-8177 |
News Archive
Midwest Research Institute (MRI), one of the nation's leading independent research organizations, with more than 65-years of experience in scientific research, has been awarded a $31 million contract from the National Institute of Environmental Health Sciences. Under the 5-year contract, MRI scientists will provide chemical procurement, handling, and analytical chemistry services requested by the National Toxicology Program (NTP) for toxicology studies in progress throughout the U.S.
A new study by the University of Toronto, found the lifetime prevalence of suicide attempts among adults who had been exposed to chronic parental domestic violence during childhood was 17.3% compared to 2.3% among those without this childhood adversity.
USC Stem Cell researcher Min Yu, MD, PhD, is one of five early-career scientists to be named a 2015 Pew-Stewart scholar for cancer research. As part of this honor, she will receive $240,000 over four years to advance the understanding of metastatic breast cancer.
St. Jude Medical Center has earned Magnet recognition, a coveted national honor earned by only 8 percent of U.S. hospitals. This award is the highest accolade in nursing excellence that any hospital can receive.
Atox Bio, a clinical stage biotechnology company engaged in the development of novel immunemodulators for severe infections in critically ill patients, announced today that the U.S. Food and Drug Administration has granted Fast Track designation to AB103, its lead product, currently in development for the treatment of Necrotizing Soft Tissue Infections (NSTI).
› Verified 2 days ago